Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Praticien-chercheur
18 articles scientifiques publiés — formation continue solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
136 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
23
23 articles ont été cités au moins 23fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
1 235
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
79
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
34
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Bicêtre Hospital
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Conservative management of brain arteriovenous malformations: results of the prospective observation registry of a pragmatic trial
2025ArticleJournal of Neurosurgery
CLinical EValuation of WEB 17 device in intracranial aneuRysms (CLEVER): procedural, 30-day and 1-year safety results for ruptured and unruptured aneurysms
2024ArticleJournal of Neurointerventional Surgery
Thromboembolic Events With the Woven Endobridge Device: Incidence, Predictive Factors, and Management
2024ArticleNeurosurgery
Patient Selection in a Pragmatic Study on the Management of Patients with Brain Arteriovenous Malformations
2023ArticleWorld Neurosurgery
Determinants of cerebral aneurysm occlusion after embolization with the WEB device: A single-institution series of 215 cases with angiographic follow-up
2023ArticleJournal of Neurointerventional Surgery
Management of aneurysmal recurrence after Woven EndoBridge (WEB) treatment
2023ArticleJournal of Neurointerventional Surgery
CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS): 12-month angiographic results of a multicenter study
2023ArticleJournal of Neurointerventional Surgery
Successful Thrombectomy Improves Functional Outcome in Tandem Occlusions with a Large Ischemic Core
2023ArticleWorld Neurosurgery
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP NUP SITE BEAUJON
100 BD DU GENERAL LECLERC, 92118 CLICHY CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Neuroradiology · 2014
Journal of neurointerventional surgery · 2022
BackgroundThe primary goal of the CLARYS study is to assess the protection against rebleeding when treating ruptured bifurcation aneurysms with the Woven EndoBridge (WEB) device.MethodsThe CLARYS study is a prospective, multicenter study conducted in 13 European centers. Patients with ruptured bifurcation aneurysms were consecutively included between February 2016 and September 2017. The primary endpoint was defined as the rebleeding rate of the target aneurysm treated with the WEB within 30 days postprocedure. Secondary endpoints included periprocedural and postprocedural adverse events, total procedure and fluoroscopy times, and modified Rankin Scale score at 1 month and 1 year.ResultsSixty patients with 60 ruptured bifurcation aneurysms to be treated with the WEB were included. A WEB device was successfully implanted in 93.3%. The rebleeding rate at 1 month and 1 year was 0%. The mean fluoroscopy time was 27.0 min. Twenty-three periprocedural complications were observed in 18 patients and resolved without sequelae in 16 patients. Two of these complications were attributed to the procedure and/or the use of the WEB, leading to a procedure/device-related intraoperative complication rate of 3.3%. Overall mortality at 1 month and 1 year was 1.7% and 3.8%, respectively and overall morbidity at 1 month and 1 year was 15% and 9.6%, respectively. WEB-related 1-month and 1-year morbidity and mortality was 0%.ConclusionsThe interim results of CLARYS show that the endovascular treatment of ruptured bifurcation aneurysms with the WEB is safe and effective and, in particular, provides effective protection against rebleeding. It may induce profound change in the endovascular management of ruptured bifurcation aneurysms.
Journal of neurointerventional surgery · 2019
BackroundThe treatment of wide neck bifurcation aneurysms remains challenging despite the introduction of new techniques (Y stenting, waffle cone technique, or flow diverter stents). The Woven EndoBridge (WEB) device is an innovative solution for this type of cerebral aneurysm. A new WEB 17 is now available and has been designed to offer smaller sized devices to optimize navigability and delivery.MethodsBetween February 2017 and April 2018 all patients treated with the WEB 17 device in our center were retrospectively reviewed. 25 patients with 28 non-ruptured aneurysms were identified and analyzed. Three patients with two aneurysms both treated with the WEB device were identified.ResultsThe device was successfully deployed in all cases. Procedure related morbidity was 4% and mortality was 0%. In one case, a delayed postprocedural thromboembolic event occurred owing to device protrusion. Technical success, complications, angiographic outcomes, procedural data, and follow-ups are reported. The modified Rankin Scale score at discharge was 0 for 24 patients (96%). At the 3, 6, or 9 month follow-up, angiograms were taken of 21 of the 25 patients (84%) (24 of 28 aneurysms had been controlled); 3 patients (3 aneurysms) did not receive angiographic follow-up at the time of submission of this work. Complete occlusion was achieved in 22 of 24 aneurysms (91.66%), and 2 of 24 aneurysm (8.33%) showed a neck remnant.ConclusionsThe WEB 17 is safe and technically feasible, according to this retrospective single center analysis. For very small bifurcation aneurysms, the WEB 17 seems to have lower complication rates than stent assisted techniques. However, further studies are needed to evaluate the complication rate and long term efficiency.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Brain sciences · 2025 · Journal Article
Elshafei O, Cortese J, Ben Achour N, Shotar E, et al.
Journal of neurointerventional surgery · 2024 · Journal Article
Guetarni Z, Bernard R, Boulouis G, Labeyrie MA, et al.
Journal of neurointerventional surgery · 2023 · Journal Article
Caroff J, Janot K, Soize S, Marnat G, et al.
Journal of neurointerventional surgery · 2022 · Journal Article
Aguiar G, Caroff J, Mihalea C, Cortese J, et al.
Journal of cerebrovascular and endovascular neurosurgery · 2021 · Case Reports
Pagiola I, Chassin O, Gallas S, Riviere MS, et al.
Journal of neurointerventional surgery · 2019 · Journal Article
Pagiola I, Mihalea C, Caroff J, Ikka L, et al.
Neuroradiology · 2014 · Clinical Study
Caroff J, Mihalea C, Dargento F, Neki H, et al.
Spine · 2013 · Case Reports
Clarençon F, Cormier E, Pascal-Moussellard H, Maldent JB, et al.
Critical care medicine · 2009 · Journal Article
Strauss J, Aboab J, Rottmann M, Porcher R, et al.
Neurosurgery · 2026 · Journal Article
de Oliveira Souza NV, Cortese J, Soize S, Chalumeau V, et al.
Journal of neurointerventional surgery · 2024 · Journal Article
Spelle L, Costalat V, Caroff J, Wodarg F, et al.
Journal of neurointerventional surgery · 2022 · Journal Article
Spelle L, Herbreteau D, Caroff J, Barreau X, et al.
Journal of neurointerventional surgery · 2025 · Journal Article
Popica DA, Cortese J, Oliver AA, Plaforet V, et al.
Neurosurgery · 2024 · Journal Article
Rodriguez-Erazú F, Cortese J, Mihalea C, Popica A, et al.
Journal of neurointerventional surgery · 2022 · Journal Article
Pediatric neurosurgery · 2022 · Journal Article
de Aguiar GB, Ozanne A, Elawady A, Samoyeau T, et al.
Journal of neurointerventional surgery · 2025 · Journal Article
Spelle L, Costalat V, Caroff J, Wodarg F, et al.
Journal of neurointerventional surgery · 2019 · Journal Article
Mihalea C, Caroff J, Pagiola I, Ikka L, et al.
Shotar E, Labeyrie MA, Biondi A, Velasco S, et al.